| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_781234f3bbb66c6fda75dc8db9f2a283 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4162 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a575a78478bd420b9e9ed01b822bbcde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41aee44c927f7f2a19616e5b06f0b84a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8745d67a388c18ed2e0be186c3dcd7f3 |
| publicationDate |
2018-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3335702-A1 |
| titleOfInvention |
Pharmaceutical compositions comprising omarigliptin |
| abstract |
The present invention relates to a pharmaceutical composition comprising omarigliptin and at least one pharmaceutically acceptable excipient, wherein the omarigliptin is in the form of a pharmaceutically acceptable acid addition salt and its use in the treatment of type-2 diabetes mellitus. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109771651-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111683659-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111683659-A |
| priorityDate |
2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |